Fortis Cunningham Road Removes 25 Abdominal Fibroids Weighing 14.9 Kgs From A 37-Year-Old Woman In An Rare Surgical Feat.
NiveshIQ
NSE: FORTIS · Healthcare
Fortis Healthcare Ltd.
₹887.80▼ ₹14.65 (-1.62%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on FORTIS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Fortis Healthcare Ltd.
Fortis Healthcare Limited operates as a diversified healthcare delivery service provider in India, offering a wide range of medical services across various specialties, including cardiology, nephrology, and oncology. The company's core business is driven by its network of hospitals and healthcare facilities, with a strong presence in the Indian market. Fortis Healthcare has reported steady growth in recent quarters, with revenue surging 17.5% in Q1FY27 to ₹9505 crore, driven by expansion efforts and increasing demand for healthcare services. The company's consolidated net profit rose 2.3% in Q1FY27, with a net income of ₹1048 crore. Fortis Healthcare's competitive position is strong, with a reputation for quality healthcare services and a large network of hospitals and healthcare facilitie
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹6,893 Cr +9.40% | ₹7,782 Cr +12.90% | ₹9,128 Cr +17.30% |
| EBITDA Margin | 18.38% | 20.41% | 23.40% |
| Net Profit | ₹645.00 Cr +1.90% | ₹809.00 Cr +25.40% | ₹1,070 Cr +32.30% |
| EPS | ₹7.93 | ₹10.26 | ₹13.80 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Fortis Cunningham Road Removes 25 Abdominal Fibroids Weighing 14.9 Kgs From A 37-Year-Old Woman In An Rare Surgical Feat.
IHH maintains it suffered losses from Fortis deal delays after ¥200 bil claim rejected
🔒
+ 3 more stories about Fortis Healthcare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹2, 545 Cr, PAT ₹273 Cr, EPS ₹3.53, EBITDA margin 21.7%. Growth context: revenue QoQ +7.6%, PAT QoQ -1.7%. Street verdict: inline, revenue surprise +1.5%, PAT surprise -3.6%.
Management commentary highlights patient or test-volume growth, mix improvement, and operating leverage as key near-term...
FY26 (last completed FY): revenue ₹9, 128 Cr, PAT ₹1, 070 Cr, EBITDA margin 23.4%, EPS ₹13.80. Year-on-year: revenue YoY...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for FORTIS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track FORTIS alongside your other holdings
Unlock full FORTIS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Fortis Healthcare Ltd.?
NiveshIQ detects active intelligence signals for Fortis Healthcare Ltd. (FORTIS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Fortis Healthcare Ltd.?
Fortis Healthcare Ltd. operates in the Healthcare sector with a market capitalisation of ₹7,163,420.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.